NYXH (Nyxoah) FFO


NYXH Nyxoah SA NYXH
65 GF Score
Price $1.69
GF Value $27.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Nyxoah FFO?

FFO (Funds from operations) only applies to REITs.

NYXH
65GF Score
Nyxoah SA NYXH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nyxoah (NYXH) Overvalued in 2026?

Based on GuruFocus' analysis, Nyxoah stock appears to be undervalued. The current stock price of $1.69 is trading 93.8% below its estimated GF Value™ of $27.39. GuruFocus considers Nyxoah to be Possible Value Trap.

Key valuation signals for NYXH:

  • FFO:
  • GF Value™: $27.39 vs. price of $1.69 (93.8% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the NYXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nyxoah Business Description

Other Exchanges 5YI:GermanyNYXH:Belgium
Address Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
65GF Score

Get the complete analysis for NYXH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.69
Price
$27.39
GF Value